Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 65.73 USD -1.84% Market Closed
Market Cap: 25.6B USD

Dexcom Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Dexcom Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Dexcom Inc
NASDAQ:DXCM
Operating Income
$777.7m
CAGR 3-Years
43%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$3.5B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$3.8B
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Operating Income
$5.4B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Operating Income
$8B
CAGR 3-Years
-6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
15%
No Stocks Found

Dexcom Inc
Glance View

Dexcom Inc. emerged as a pioneering force in the realm of continuous glucose monitoring (CGM), redefining the landscape of diabetes management. Founded in 1999, this San Diego-based company disrupted traditional blood glucose monitoring with its innovative technology, allowing individuals to track glucose levels in real-time without frequent finger-pricking. The company’s CGM systems, such as the G6 model, utilize a small sensor inserted beneath the skin that transmits data to a wearable device or smartphone, allowing patients and healthcare providers a comprehensive view of glucose trends. This approach empowers users with critical information for better diabetes management, reducing the likelihood of complications resulting from high or low blood sugar. Dexcom’s revenue generation revolves around the sales of its CGM systems, sensors, and related software services. By selling the initial monitoring devices and disposable sensors that typically need to be replaced every ten days, the company ensures a steady, recurring revenue stream. Furthermore, its integration with healthcare providers and insurers broadens its reach, tapping into a vast network of patients worldwide. Dexcom also collaborates with tech giants to enhance interoperability and data analytics, thereby embedding its solutions in broader digital health ecosystems. As diabetes continues to be a growing global concern, Dexcom’s strategic focus on innovation and strategic partnerships positions it as a leader in the CGM market.

DXCM Intrinsic Value
58.79 USD
Overvaluation 11%
Intrinsic Value
Price

See Also

What is Dexcom Inc's Operating Income?
Operating Income
777.7m USD

Based on the financial report for Sep 30, 2025, Dexcom Inc's Operating Income amounts to 777.7m USD.

What is Dexcom Inc's Operating Income growth rate?
Operating Income CAGR 5Y
20%

Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for Dexcom Inc have been 43% over the past three years , 20% over the past five years .

Back to Top